The first and only agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsy,* LYMPHOSEEK provides accurate and precise lymph node identification in patients with solid tumors.
Mechanism of Action
Clinical Efficacy: Solid Tumors
Review this section for more information on how to use LYMPHOSEEK in your patients to assist in the localization of lymph nodes draining a primary tumor site.
Dosing and Administration
Cardinal Health Nuclear & Precision Health Solutions Resources
LYMPHOSEEK® demonstrated rapid injection site clearance and lymph node accumulation with the first node visualizing 5 minutes after injection.
Download the case study
1.8MB - PDF
Lymphatic mapping and SLNB with LYMPHOSEEK® should be performed between 15 minutes and 15 hours post-injection.1
References: 1. Lymphoseek [package insert]. Dublin, OH: Cardinal Health, Inc.; 2019.